BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25586243)

  • 1. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
    Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
    Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
    Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
    Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
    BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
    Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
    J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
    Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
    Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.
    Samsom KG; Levy S; van Veenendaal LM; Roepman P; Kodach LL; Steeghs N; Valk GD; Wouter Dercksen M; Kuhlmann KFD; Verbeek WHM; Meijer GA; Tesselaar MET; van den Berg JG
    Histopathology; 2021 Mar; 78(4):556-566. PubMed ID: 32931025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
    Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
    Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
    Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C
    Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
    Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
    Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiomic sequencing of paired primary and metastatic small bowel carcinoids.
    Postel MD; Darabi S; Howe JR; Liang WS; Craig DW; Demeure MJ
    F1000Res; 2023; 12():417. PubMed ID: 37954063
    [No Abstract]   [Full Text] [Related]  

  • 12. MEN4 and
    Alrezk R; Hannah-Shmouni F; Stratakis CA
    Endocr Relat Cancer; 2017 Oct; 24(10):T195-T208. PubMed ID: 28824003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine.
    Elias E; Ardalan A; Lindberg M; Reinsbach SE; Muth A; Nilsson O; Arvidsson Y; Larsson E
    Nat Commun; 2021 Nov; 12(1):6367. PubMed ID: 34737276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
    Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P
    Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.
    Walter D; Harter PN; Battke F; Winkelmann R; Schneider M; Holzer K; Koch C; Bojunga J; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Waidmann O
    Sci Rep; 2018 Feb; 8(1):3811. PubMed ID: 29491456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases.
    Frederiksen A; Rossing M; Hermann P; Ejersted C; Thakker RV; Frost M
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3637-3646. PubMed ID: 30990521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
    Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling.
    Norlén O; Edfeldt K; Akerstrom G; Westin G; Hellman P; Bjorklund P; Stalberg P
    Surgery; 2014 Dec; 156(6):1512-21; discussion 1521-2. PubMed ID: 25456945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.
    Chasseloup F; Pankratz N; Lane J; Faucz FR; Keil MF; Chittiboina P; Kay DM; Hussein Tayeb T; Stratakis CA; Mills JL; Hernández-Ramírez LC
    J Clin Endocrinol Metab; 2020 Jun; 105(6):1983-2005. PubMed ID: 32232325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.